The latest market report published by Acute Market Reports “Global Breast Imaging Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global breast imaging market was valued at US$ 2,334.2 Mn in 2017, and is expected to reach US$ 4,945.3 Mn by 2026, expanding at a CAGR of 8.7% from 2018 to 2026.

Market Insights

According to American Cancer Society (ACS) research findings breast cancer is typically manifested with no symptoms when the tumor is small which makes early detection of prime importance. The most com+++mon physical symptom is a painless lump. In certain cases the cancer spreads in the lymph nodes present in the underarms region. The other symptoms related to breast cancer are breast pain, thickening, and nipple abnormalities such as erosion & blood discharge. Breast cancer is classified on the basis of location and aggressiveness of the disease. Ductal carcinoma is the most common type which occurs within the ducts that transport milk to the nipple. Metastatic breast cancer, inflammatory breast cancer, and triple negative breast cancer are the other types of breast cancer occurring in the women population. The occurrence is highly variable in different ethnic and racial groups throughout the globe.

Browse the full report Breast Imaging Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 at  https://www.acutemarketreports.com/report/breast-imaging-market

Mammography is still considered as the most preferred equipment for the diagnosis of breast cancer. The limitations associated with mammography are the false positive and false negative inferences which results in more diagnostic tests and follow up visits which becomes stressful for the ailing patient. Tomosynthesis is the advanced version of mammography which provides high resolution 3D images of breast related diseases. Breast ultrasound will register rapid growth during the forecast period 2018 to 2026 on account of key parameters such as high resolution, better patient compliance during diagnosis and safety in pregnant women & women with breast implants as there is no risk of radiation exposure.

In the present scenario North America is leading the regional segment owing to key factors such as rising prevalence of breast cancer in women population availing hormone replacement therapy. Domicile of market leaders in the breast imaging devices such as Philips Healthcare and Siemens Healthcare GmbH drive the market growth in Europe. Asia Pacific is set to register impressive growth during the forecast period on account of proactive government initiatives to educate women regarding breast cancer and implementing effective diagnosis at primary healthcare centers. Middle East & Africa and Latin America serve as a lucrative market for key players to promote business expansion through inorganic and organic market growth strategies.

The market leaders that influence the breast imaging market growth are Aurora Imaging Technology, Inc., Dilon Technologies, Inc., Fujifilm Holding Corporation, GE Healthcare, Gamma Medica, Inc., Hologic, Inc., Philips Healthcare, Sonocine, Inc., Toshiba Corporation and Siemens Healthcare GmbH.

Key Market Movements:

• Rising prevalence of breast cancer and increasing public health awareness regarding cancer chemotherapy and its adverse effects
• Supportive regulatory environment for the market growth of breast imaging devices
• Technological advancement in the ergonomics and diagnosis parameters installed in the breast imaging devices

The Global Breast Imaging Market is Segmented into:

*Complete segmentation list is on report page